Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
CC transcript
Inv. presentation
Credit agrmnt [a]
Acq. announced
Director departure
Appointed director
Employment agrmnt
|
|
AMAG PHARMACEUTICALS, INC. (AMAG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Palo Alto Investors LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| Camber Capital Management LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/14/2020 |
GN
| AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration's Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection) |
| 11/27/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/17/2020 |
4
| SCOON DAVEY (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 43,898 shares
@ $0
Disposed/sold 3,800 options to buy
@ $0
Disposed/sold 3,575 options to buy
@ $0
Disposed/sold 12,787 options to buy
@ $0
Disposed/sold 10,110 options to buy
@ $0
Disposed/sold 7,543 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Phillips Anne M. (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 18,949 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 1,200 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| JOHNSON DAVID EDWARD (10% Owner) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 14,676 shares
@ $0
Disposed/sold 3,499,428 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 9,452 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 3,499,428 shares
@ $0 |
|
| 11/17/2020 |
4
| Schick Kelly (Chief Human Resources Officer) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 28,155 shares
@ $0
Disposed/sold 7,000 options to buy
@ $0
Disposed/sold 6,900 options to buy
@ $0
Disposed/sold 17,000 options to buy
@ $0 |
|
| 11/17/2020 |
4
| SULAT JAMES R (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 35,090 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 317 options to buy
@ $0
Disposed/sold 3,800 options to buy
@ $0
Disposed/sold 3,575 options to buy
@ $0
Disposed/sold 12,787 options to buy
@ $0
Disposed/sold 10,110 options to buy
@ $0
Disposed/sold 7,543 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Vittiglio Joseph (Chief Business Officer, GC) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 92,244 shares
@ $0
Disposed/sold 30,000 options to buy
@ $0
Disposed/sold 20,000 options to buy
@ $0
Disposed/sold 25,000 options to buy
@ $0
Disposed/sold 35,000 options to buy
@ $0 |
|
| 11/17/2020 |
4
| SANTINI GINO (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 41,473 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 950 options to buy
@ $0
Disposed/sold 3,800 options to buy
@ $0
Disposed/sold 7,600 options to buy
@ $0
Disposed/sold 3,575 options to buy
@ $0
Disposed/sold 12,787 options to buy
@ $0
Disposed/sold 10,110 options to buy
@ $0
Disposed/sold 7,543 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| O'Brien Kathrine (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 18,949 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 1,200 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Myers Scott Dunseth (President & CEO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 1,000,000 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Piekos Brian (CFO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 31,538 shares
@ $0
Disposed/sold 9,500 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Fallon John A. (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 37,362 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 2,534 options to buy
@ $0
Disposed/sold 3,575 options to buy
@ $0
Disposed/sold 12,787 options to buy
@ $0
Disposed/sold 10,110 options to buy
@ $0
Disposed/sold 7,543 options to buy
@ $0
Disposed/sold 17,326 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/17/2020 |
4
| Casciano Anthony (COO) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 76,349 shares
@ $0
Disposed/sold 20,000 options to buy
@ $0
Disposed/sold 8,000 options to buy
@ $0
Disposed/sold 18,000 options to buy
@ $0
Disposed/sold 16,156 options to buy
@ $0
Disposed/sold 25,000 options to buy
@ $0
Disposed/sold 40,000 options to buy
@ $0 |
|
| 11/17/2020 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 14,676 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 9,452 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 11/16/2020 |
SC 13D/A
| Caligan Partners LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 11/16/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/16/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/13/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/13/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/06/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 11/06/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/30/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Eaton Vance Corp., MobileIron, Inc., and Seacoast Commerce Banc Holdings |
| 10/26/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/26/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/15/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of AMAG Pharmaceuticals, Inc. Buyout |
| 10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), MobileIron, Inc. (NASDAQ GS: MOBL), Seacoast Commerce Banc Holdings (OTC: SCBH), and Perceptron, Inc. (NASDAQ GS: PRCP) |
| 10/15/2020 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/15/2020 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/14/2020 |
GN
| AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients |
|
|
|